Diagnostic work-up and therapeutic options in management of pediatric status epilepticus

World Journal of Pediatrics

Volumn 8, Issue 2, 2012, Pages 109-115

  Mastrangelo, Mario ^a   Celato, Andrea ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antiepileptic drugs; Children; Status epilepticus

Indexed keywords

DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; HARKOSERIDE; LORAZEPAM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PROPOFOL; PYRIDOXINE; THIOPENTAL; TOPIRAMATE; VALPROIC ACID; VERAPAMIL;

BRAIN MALFORMATION; BRAIN TUMOR; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CLINICAL PROTOCOL; DEMYELINATING DISEASE; DIPLOPIA; DISEASE CLASSIFICATION; DIZZINESS; DRUG HALF LIFE; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HEADACHE; HUMAN; LOADING DRUG DOSE; MORBIDITY; PATHOPHYSIOLOGY; REVIEW; SOMNOLENCE; STROKE; TONIC CLONIC SEIZURE; CHILD;

CHILD; HUMANS; STATUS EPILEPTICUS;

EID: 84866256885     PISSN: 17088569     EISSN: 18670687     Source Type: Journal    
DOI: 10.1007/s12519-012-0348-2     Document Type: Review

References (61)

1. Lowenstein DH, Bleck T, Macdonald RL. It's time to revise the defi nition of status epilepticus. Epilepsia 1999;40:120-122. (Pubitemid 29031765)
2. Meierkord H, Boon P, Engelsen B, Göcke K, Shorvon S, Tinuper P, et al. EFNS guideline on the management of status epilepticus. Eur J Neurol 2006;13:445-450. (Pubitemid 43823356)
3. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51:676-685.
4. Guerrini R. Epilepsy in children. Lancet 2006;367:499-524. (Pubitemid 43208906)
5. Neville BG, Chin RF, Scott RC. Childhood convulsive status epilepticus: epidemiology, management and outcome. Acta Neurol Scand Suppl 2007;186:21-24. (Pubitemid 46376167)
6. Riviello JJ Jr, Ashwal S, Hirtz D, Glauser T, Ballaban-Gil K, Kelley K, et al. Practice parameter: diagnostic assessment of the child with status epilepticus (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2006;67:1542-1550. (Pubitemid 44747921)
7. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46:1029-1035. (Pubitemid 26134646)
8. Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology 1998;50:735-741.
9. Novorol CL, Chin RF, Scott RC. Outcome of convulsive status epilepticus: a review. Arch Dis Child 2007;92:948-951. (Pubitemid 350043965)
10. Kravljanac R, Jovic N, Djuric M, Jankovic B, Pekmezovic T. Outcome of status epilepticus in children treated in the intensive care unit: a study of 302 cases. Epilepsia 2011;52:358-363.
11. Pujar SS, Neville BG, Scott RC, Chin RF; North London Epilepsy Research Network. Death within 8 years after childhood convulsive status epilepticus: a population-based study. Brain 2011;134(Pt 10):2819-2827.
12. Garzon E, Fernandes RM, Sakamoto AC. Analysis of clinical characteristics and risk factors for mortality in human status epilepticus. Seizure 2003;12:337-345. (Pubitemid 37062762)
13. Wilder-Smith EP, Lim EC, Teoh HL, Sharma VK, Tan JJ, Chan BP, et al. The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity. Ann Acad Med Singapore 2005;34:417-420. (Pubitemid 41290847)
14. Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 2011;134(Pt 10):2802-2818.
15. Chen JW, Naylor DE, Wasterlain CG. Advances in the pathophysiology of status epilepticus. Acta Neurol Scand 2007;115(4 Suppl):7-15. (Pubitemid 46376165)
16. Deshpande LS, Lou JK, Mian A, Blair RE, Sombati S, Attkisson E, et al. Time course and mechanism of hippocampal neuronal death in an in vitro model of status epilepticus: role of NMDA receptor activation and NMDA dependent calcium entry. Eur J Pharmacol 2008;583:73-83.
17. Schauwecker PE. Neuroprotection by glutamate receptor antagonists against seizure-induced excitotoxic cell death in the aging brain. Exp Neurol 2010;224:207-218.
18. Ngomba RT, Santolini I, Salt TE, Ferraguti F, Battaglia G, Nicoletti F, et al. Metabotropic glutamate receptors in the thalamocortical network: strategic targets for the treatment of absence epilepsy. Epilepsia 2011;52:1211-1222.
19. Engel T, Tanaka K, Jimenez-Mateos EM, Caballero-Caballero A, Prehn JH, Henshall DC. Loss of p53 results in protracted electrographic seizures and development of an aggravated epileptic phenotype following status epilepticus. Cell Death Dis 2010;1:e79.
20. Engel T, Hatazaki S, Tanaka K, Prehn JH, Henshall DC. Deletion of Puma protects hippocampal neurons in a model of severe status epilepticus. Neuroscience 2010;168:443-450.
21. Löscher W, Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 2005;6:591- 602. (Pubitemid 41059334)
22. Kuteykin-Teplyakov K, Brandt C, Hoffmann K, Löscher W. Complex time-dependent alterations in the brain expression of different drug efflux transporter genes after status epilepticus. Epilepsia 2009;50:887-897.
23. Löscher W. Molecular mechanisms of drug resistance in status epilepticus. Epilepsia 2009;50 Suppl 12:19-21.
24. Fountain NB. Status epilepticus: risk factors and complications. Epilepsia 2000;41 Suppl 2:S23-30. (Pubitemid 30387358)
25. Nandhagopal R. Generalised convulsive status epilepticus: an overview. Postgrad Med J 2006;82:723-732.
26. Maytal J, Novak G, Ascher C, Bienkowski R. Status epilepticus in children with epilepsy: the role of antiepileptic drug levels inprevention. Pediatrics 1996;98(6 Pt 1):1119-1121. (Pubitemid 26399275)
27. Barry E, Hauser WA. Status epilepticus and antiepileptic medication levels. Neurology 1994;44:47-50. (Pubitemid 24029427)
28. Knake S, Hamer HM, Rosenow F. Status epilepticus: a critical review. Epilepsy Behav 2009;15:10-14.
29. Chin RF, Neville BG, Scott RC. Meningitis is a common cause of convulsive status epilepticus with fever. Arch Dis Child 2005;90:66-69. (Pubitemid 40052257)
30. Hirtz D, Ashwal S, Berg A, Bettis D, Camfield C, Camfield P, et al. Practice parameter: evaluating a first nonfebrile seizure in children: report of the quality standards subcommittee of the American Academy of Neurology, The Child Neurology Society, and The American Epilepsy Society. Neurology 2000;55:616- 623
31. Berg AT, Shinnar S, Levy SR, Testa FM. Status epilepticus in children with newly diagnosed epilepsy. Ann Neurol 1999;45:618-623 (Pubitemid 29217590)
32. Mastrangelo M, Celato A, Leuzzi V. A diagnostic algorithm for the evaluation of early onset genetic-metabolic epileptic encephalopathies. Eur J Paediatr Neurol 2012;16:179-191.
33. Abdel Baki SG, Omurtag A, Fenton AA, Zehtabchi S. The new wave: time to bring EEG to the emergency department. Int J Emerg Med 2011;4:36.
34. Brenner RP. EEG in convulsive and nonconvulsive status epilepticus. J Clin Neurophysiol 2004;21:319-331. (Pubitemid 39628123)
35. Chong DJ, Hirsch LJ. Which EEG patterns warrant treatment in the critically ill? Reviewing the evidence for treatment of periodic epileptiform discharges and related patterns. J Clin Neurophysiol 2005;22:79-91. (Pubitemid 40490399)
36. Ferrie CD, Caraballo R, Covanis A, Demirbilek V, Dervent A, Fejerman N, et al. Autonomic status epilepticus in Panayiotopoulos syndrome and other childhood and adult epilepsies: a consensus view. Epilepsia 2007;48:1165-1172. (Pubitemid 46854878)
37. Nickels K, Wirrell E. Electrical status epilepticus in sleep. Semin Pediatr Neurol 2008;15:50-60. (Pubitemid 351794546)
38. Scott RC, Gadian DG, King MD, Chong WK, Cox TC, Neville BG, et al. Magnetic resonance imaging fi ndings within 5 days of status epilepticus in childhood. Brain 2002;125(Pt 9):1951-1959.
39. Minicucci F, Muscas G, Perucca E, Capovilla G, Vigevano F, Tinuper P. Treatment of status epilepticus in adults: guidelines of the Italian League against Epilepsy. Epilepsia 2006;47 Suppl 5:9-15. (Pubitemid 44924185)
40. Treiman DM. The role of benzodiazepines in the management of status epilepticus. Neurology 1990;40(5 Suppl 2):32-42.
41. Sofou K, Kristjánsdóttir R, Papachatzakis NE, Ahmadzadeh A, Uvebrant P. Management of prolonged seizures and status epilepticus in childhood: a systematic review. J Child Neurol 2009;24:918-926.
42. Mpimbaza A, Ndeezi G, Staedke S, Rosenthal PJ, Byarugaba J. Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in Ugandan children: a randomized clinical trial. Pediatrics 2008;121:e58-64.
43. Lahat E, Goldman M, Barr J, Bistritzer T, Berkovitch M. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. BMJ 2000;321:83-86. (Pubitemid 30438483)
44. Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet 1999;353:623-626. (Pubitemid 29087982)
45. Gospe SM Jr. Neonatal vitamin-responsive epileptic encephalopathies. Chang Gung Med J 2010;33:1-12.
46. Eriksson K, Keränen T, Kälviäinen R. Fosphenytoin. Expert Opin Drug Metab Toxicol 2009;5:695-701.
47. Yamamoto LG, Yim GK. The role of intravenous valproic acid in status epilepticus. Pediatr Emerg Care 2000;16:296-298. (Pubitemid 30644337)
48. Sheth RD, Gidal BE. Intravenous valproic acid for myoclonic status epilepticus. Neurology 2000;54:1201. (Pubitemid 30151873)
49. Uberall MA, Trollmann R, Wunsiedler U, Wenzel D. Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus. Neurology 2000;54:2188-2189. (Pubitemid 30397234)
50. Embacher N, Karner E, Wanschitz J, Beer R, Trinka E. Acute encephalopathy after intravenous administration of valproate in non-convulsive status epilepticus. Eur J Neurol 2006;13:e5-6. (Pubitemid 44434306)
51. Gallentine WB, Hunnicutt AS, Husain AM. Levetiracetam in children with refractory status epilepticus. Epilepsy Behav 2009;14:215-218.
52. Höfl er J, Unterberger I, Dobesberger J, Kuchukhidze G, Walser G, Trinka E. Intravenous lacosamide in status epilepticus and seizure clusters. Epilepsia 2011;52:e148-152.
53. Shiloh-Malawsky Y, Fan Z, Greenwood R, Tennison M. Successful treatment of childhood prolonged refractory status epilepticus with lacosamide. Seizure 2011;20:586-588.
54. Tarulli A, Drislane FW. The use of topiramate in refractory status epilepticus. Neurology 2004;62:837. (Pubitemid 38298979)
55. Kahriman M, Minecan D, Kutluay E, Selwa L, Beydoun A. Efficacy of topiramate in children with refractory status epilepticus. Epilepsia 2003;44:1353-1356. (Pubitemid 37280381)
56. Bensalem MK, Fakhoury TA. Topiramate and status epilepticus: report of three cases. Epilepsy Behav 2003;4:757-760. (Pubitemid 38035702)
57. Perry MS, Holt PJ, Sladky JT. Topiramate loading for refractory status epilepticus in children. Epilepsia 2006;47:1070-1071. (Pubitemid 43801519)
58. Kang TM. Propofol infusion syndrome in critically ill patients. Ann Pharmacother 2002;36:1453-1456. (Pubitemid 34925283)
59. van Gestel JP, Blussévan Oud-Alblas HJ, Malingré M, Ververs FF, Braun KP, van Nieuwenhuizen O. Propofol and thiopental for refractory status epilepticus in children. Neurology 2005;65:591- 592. (Pubitemid 41170720)
60. Schmitt FC, Dehnicke C, Merschhemke M, Meencke HJ. Verapamil attenuates the malignant treatment course in recurrent status epilepticus. Epilepsy Behav 2010;17:565-568.
61. Iannetti P, Spalice A, Parisi P. Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus. Epilepsia 2005;46:967-969. (Pubitemid 40847369)